HUE066562T2 - Eljárások szennyezés eltávolítására indigén fehérje kiszorításos ioncserés membrán kromatográfia alkalmazásával - Google Patents

Eljárások szennyezés eltávolítására indigén fehérje kiszorításos ioncserés membrán kromatográfia alkalmazásával

Info

Publication number
HUE066562T2
HUE066562T2 HUE19181531A HUE19181531A HUE066562T2 HU E066562 T2 HUE066562 T2 HU E066562T2 HU E19181531 A HUE19181531 A HU E19181531A HU E19181531 A HUE19181531 A HU E19181531A HU E066562 T2 HUE066562 T2 HU E066562T2
Authority
HU
Hungary
Prior art keywords
contaminant
methods
ion exchange
exchange membrane
membrane chromatography
Prior art date
Application number
HUE19181531A
Other languages
English (en)
Hungarian (hu)
Inventor
Arick Brown
Jerome Bill
Timothy Tully
Christopher Dowd
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39899038&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE066562(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of HUE066562T2 publication Critical patent/HUE066562T2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HUE19181531A 2008-08-14 2008-08-14 Eljárások szennyezés eltávolítására indigén fehérje kiszorításos ioncserés membrán kromatográfia alkalmazásával HUE066562T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2008/073179 WO2010019148A1 (en) 2008-08-14 2008-08-14 Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography
EP19181531.5A EP3604324B1 (en) 2008-08-14 2008-08-14 Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography

Publications (1)

Publication Number Publication Date
HUE066562T2 true HUE066562T2 (hu) 2024-08-28

Family

ID=39899038

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE14189582A HUE047316T2 (hu) 2008-08-14 2008-08-14 Eljárások szennyezés eltávolítására indigén fehérjekiszorításos ioncserés membrán kromatográfia alkalmazásával
HUE19181531A HUE066562T2 (hu) 2008-08-14 2008-08-14 Eljárások szennyezés eltávolítására indigén fehérje kiszorításos ioncserés membrán kromatográfia alkalmazásával

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HUE14189582A HUE047316T2 (hu) 2008-08-14 2008-08-14 Eljárások szennyezés eltávolítására indigén fehérjekiszorításos ioncserés membrán kromatográfia alkalmazásával

Country Status (22)

Country Link
US (2) US10927144B2 (enExample)
EP (3) EP2848625B1 (enExample)
JP (1) JP5666447B2 (enExample)
KR (3) KR101843915B1 (enExample)
CN (1) CN102149724B (enExample)
AU (1) AU2008360625C1 (enExample)
BR (1) BRPI0823046B1 (enExample)
CA (1) CA2731943C (enExample)
CY (1) CY1122221T1 (enExample)
DK (2) DK2848625T3 (enExample)
ES (3) ES2978373T3 (enExample)
FI (1) FI3604324T3 (enExample)
HR (2) HRP20240472T1 (enExample)
HU (2) HUE047316T2 (enExample)
IL (2) IL210912B (enExample)
LT (2) LT3604324T (enExample)
MX (1) MX2011001506A (enExample)
PL (2) PL3604324T3 (enExample)
PT (2) PT3604324T (enExample)
RS (1) RS59232B1 (enExample)
SI (2) SI3604324T1 (enExample)
WO (1) WO2010019148A1 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
CA2842964A1 (en) 2006-09-13 2008-03-20 Abbvie Inc. Cell culture improvements
DK2848625T3 (da) 2008-08-14 2019-10-07 Genentech Inc Fremgangsmåder til fjernelse af en kontaminant under anvendelse af ion bytningsmembrankromatografi med forskydning af naturligt forekommende proteiner
NZ592095A (en) 2008-10-20 2013-01-25 Abbott Lab Isolation and purification of il-12 and tnf-alpha antibodies using protein a affinity chromatography
AU2009307737B2 (en) 2008-10-20 2015-07-23 Abbvie Inc. Viral inactivation during purification of antibodies
CA2799915C (en) 2010-05-25 2023-09-26 Genentech, Inc. Methods of purifying polypeptides
WO2012030512A1 (en) * 2010-09-03 2012-03-08 Percivia Llc. Flow-through protein purification process
EP2649088A4 (en) * 2010-12-10 2014-09-03 Tracy Thompson COMPOSITIONS FOR SEPARATION METHODS
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
HRP20181846T1 (hr) * 2011-12-22 2018-12-28 Genentech, Inc. Kromatografija membranom za ionsku izmjenu
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
WO2014133458A1 (en) * 2013-02-26 2014-09-04 Agency For Science, Technology And Research Protein purification in the presence of nonionic organic polymers and electropositive surfaces
HK1207960A1 (en) 2013-03-12 2016-02-19 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
EP2987801B1 (en) * 2013-04-16 2019-06-12 Asahi Kasei Medical Co., Ltd. Method for the removal of aggregates from a solution containing an antibody protein
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
US9546208B2 (en) 2014-01-03 2017-01-17 Bio-Rad Laboratories, Inc. Removal of impurities from protein A eluates
EP3510042B1 (en) * 2016-09-07 2024-05-22 GlaxoSmithKline Intellectual Property Development Limited Methods for purifying antibodies
EP3509729A1 (en) 2016-09-09 2019-07-17 3M Innovative Properties Company Functionalized copolymers and use thereof
US10053368B1 (en) * 2017-09-07 2018-08-21 Chevron U.S.A. Inc. Synthesis of AFX framework type molecular sieves
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
TWI814812B (zh) * 2018-05-02 2023-09-11 美商里珍納龍藥品有限公司 用於評估生化過濾器的適合性的方法
CN112566930A (zh) * 2018-06-19 2021-03-26 百时美施贵宝公司 使用色谱纯化蛋白质的方法
CN109324143B (zh) * 2018-10-19 2021-10-29 张骐 利用二维液相分离制备抗体类产品相关杂质的方法
CN109806916B (zh) * 2019-03-15 2021-12-21 中科森辉微球技术（苏州）有限公司 高性能阴离子交换介质及其制备方法
GB201911685D0 (en) * 2019-08-15 2019-10-02 Fujifilm Diosynth Biotechnologies Uk Ltd Process for purifying monoclonal antibodies
CN116802206A (zh) * 2020-12-28 2023-09-22 等离子体技术有限责任公司 用于生产规模的免疫球蛋白g分离系统和方法
KR20220112014A (ko) 2021-02-03 2022-08-10 고인석 십전대보탕을 이용하여 만든 오리목뼈 간식
CN118290514B (zh) * 2024-06-05 2025-04-04 东曜药业有限公司 基于阴离子膜的抗体偶联药物的纯化方法及抗体偶联药物

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US4347322A (en) 1981-01-12 1982-08-31 Nabisco Brands, Inc. Chromatographic process for enzyme purification
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US5091178A (en) 1986-02-21 1992-02-25 Oncogen Tumor therapy with biologically active anti-tumor antibodies
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
ATE113846T1 (de) 1988-06-21 1994-11-15 Genentech Inc Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
DE68925971T2 (de) 1988-09-23 1996-09-05 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
ATE233813T1 (de) 1991-08-14 2003-03-15 Genentech Inc Veränderte immunglobuline für spezifische fc- epsilon rezeptoren
EP0617706B1 (en) 1991-11-25 2001-10-17 Enzon, Inc. Multivalent antigen-binding proteins
DE69334255D1 (de) 1992-02-06 2009-02-12 Novartis Vaccines & Diagnostic Marker für Krebs und biosynthetisches Bindeprotein dafür
JPH08500826A (ja) 1992-08-21 1996-01-30 ジェネンテク，インコーポレイテッド Ｌｆａ−１仲介疾患を処置する方法
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5595721A (en) 1993-09-16 1997-01-21 Coulter Pharmaceutical, Inc. Radioimmunotherapy of lymphoma using anti-CD20
CA2106612C (en) * 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
DE69405251T2 (de) 1993-12-10 1998-02-05 Genentech Inc Methoden zur diagnose von allergie und prüfung anti-allergischer therapeutika
MX9602818A (es) 1994-01-18 1997-06-28 Genentech Inc Un metodo de tratamiento de infeccion parasitaria usando antagonistas ige.
MX9603773A (es) 1994-03-03 1997-07-31 Genentech Inc Anticuerpos monoclonales anti-interleucina-8 para el tratamiento de trastornos inflamatorios.
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
EP0831880A4 (en) 1995-06-07 2004-12-01 Imclone Systems Inc ANTIBODIES AND FRAGMENTS OF ANTIBODIES INHIBITING TUMOR GROWTH
PT877626E (pt) 1996-01-23 2003-01-31 Univ Vermont And State Agric C Anticorpos anti-cd1s para utilizacao contra icto
US6592905B1 (en) 1996-01-31 2003-07-15 Massey University Production of an immunoglobulin enriched fraction from whey protein solutions
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
DE122004000047I1 (de) 1996-11-27 2005-04-21 Genentech Inc Humanisierte anti-koerper gegen cd11a.
WO1998045331A2 (en) 1997-04-07 1998-10-15 Genentech, Inc. Anti-vegf antibodies
ATE516354T1 (de) 1997-05-15 2011-07-15 Genentech Inc Apo-2-rezeptor
KR20010043323A (ko) 1998-05-06 2001-05-25 제넨테크, 인크. 이온 교환 크로마토그래피에 의한 단백질 정제 방법
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
WO2001040309A2 (en) 1999-10-29 2001-06-07 Genentech, Inc. Anti-prostate stem cell antigen (psca) antibody compositions and methods of use
US6479636B1 (en) * 2000-04-11 2002-11-12 Honiron Corporation (A Louisiana Corporation) Sugarcane fractioning system
US6633462B2 (en) 2000-07-13 2003-10-14 Koninklijke Philips Electronics N.V. Magnetoresistive angle sensor having several sensing elements
UA83458C2 (uk) 2000-09-18 2008-07-25 Байоджен Айдек Ма Інк. Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
GB2372464B (en) * 2001-02-22 2003-05-14 Vivascience Ltd Method of isolating a charged compound
US7321026B2 (en) 2001-06-27 2008-01-22 Skytech Technology Limited Framework-patched immunoglobulins
WO2003033658A2 (en) 2001-10-17 2003-04-24 Human Genome Sciences, Inc. Neutrokine-alpha and neutrokine-alpha splice variant
US20040093621A1 (en) 2001-12-25 2004-05-13 Kyowa Hakko Kogyo Co., Ltd Antibody composition which specifically binds to CD20
EP2295468B1 (en) 2002-02-14 2015-07-08 Immunomedics, Inc. Anti-CD20 antibodies and fusion proteins thereof and methods of use
HUE025101T2 (en) * 2002-04-26 2016-02-29 Genentech Inc Purification of proteins other than affinity purification
ES2558303T3 (es) * 2002-09-11 2016-02-03 Chugai Seiyaku Kabushiki Kaisha Método de purificación de proteínas
KR100932340B1 (ko) 2002-10-17 2009-12-16 젠맵 에이/에스 Ｃｄ20에 대한 인간 모노클로날 항체
CN103833854B (zh) 2002-12-16 2017-12-12 健泰科生物技术公司 免疫球蛋白变体及其用途
KR101412271B1 (ko) 2003-05-09 2014-06-25 듀크 유니버시티 Ｃｄ２０-특이적 항체 및 이를 이용한 방법
AR044388A1 (es) 2003-05-20 2005-09-07 Applied Molecular Evolution Moleculas de union a cd20
JP4818917B2 (ja) 2003-08-08 2011-11-16 イミューノメディクス、インコーポレイテッド 腫瘍および罹患細胞のアポトーシスを誘発するための二重特異性抗体
US8147832B2 (en) 2003-08-14 2012-04-03 Merck Patent Gmbh CD20-binding polypeptide compositions and methods
KR101221862B1 (ko) 2003-10-27 2013-01-14 와이어쓰 엘엘씨 하이드록시아파타이트 크로마토그래피를 사용한 고분자량응집체의 제거
KR101363120B1 (ko) 2005-02-10 2014-02-13 베일러 리서치 인스티튜트 항-인터페론 알파 모노클로날 항체 및 사용 방법
ES2797480T3 (es) † 2005-03-11 2020-12-02 Wyeth Llc Un procedimiento de cromatografía de reparto débil
KR20080111487A (ko) † 2006-03-20 2008-12-23 메다렉스, 인코포레이티드 단백질 정제 방법
WO2008057683A2 (en) * 2006-10-03 2008-05-15 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
WO2009135656A1 (en) 2008-05-06 2009-11-12 Lonza Biologics Plc. A method for the purification of antibodies using displacement chromatography
DK2848625T3 (da) 2008-08-14 2019-10-07 Genentech Inc Fremgangsmåder til fjernelse af en kontaminant under anvendelse af ion bytningsmembrankromatografi med forskydning af naturligt forekommende proteiner
WO2015198451A1 (ja) 2014-06-26 2015-12-30 楽天株式会社 情報処理装置、情報処理方法及び情報処理プログラム

Also Published As

Publication number Publication date
DK2848625T3 (da) 2019-10-07
SI2848625T1 (sl) 2019-11-29
CN102149724B (zh) 2014-04-09
IL262657B (en) 2021-03-25
KR20180137591A (ko) 2018-12-27
AU2008360625B2 (en) 2016-05-19
WO2010019148A1 (en) 2010-02-18
PT3604324T (pt) 2024-05-10
RS59232B1 (sr) 2019-10-31
JP5666447B2 (ja) 2015-02-12
KR102196883B1 (ko) 2020-12-30
EP2321337A1 (en) 2011-05-18
HK1210181A1 (en) 2016-04-15
HRP20240472T1 (hr) 2024-06-21
US20210284685A1 (en) 2021-09-16
EP2321337B2 (en) 2018-10-10
BRPI0823046B1 (pt) 2021-12-14
PT2848625T (pt) 2019-10-25
KR101843915B1 (ko) 2018-04-02
EP2321337B1 (en) 2014-10-22
HUE047316T2 (hu) 2020-04-28
AU2008360625C1 (en) 2017-01-19
KR20180033311A (ko) 2018-04-02
CY1122221T1 (el) 2020-11-25
EP2848625B1 (en) 2019-07-31
PL2848625T3 (pl) 2020-01-31
US10927144B2 (en) 2021-02-23
EP3604324B1 (en) 2024-02-28
EP2848625A1 (en) 2015-03-18
PL3604324T3 (pl) 2024-07-01
LT3604324T (lt) 2024-05-10
CA2731943C (en) 2016-11-29
ES2527943T5 (es) 2019-03-07
DK3604324T3 (da) 2024-04-08
CA2731943A1 (en) 2010-02-18
LT2848625T (lt) 2019-10-10
EP3604324A1 (en) 2020-02-05
HRP20191848T1 (hr) 2019-12-27
FI3604324T3 (fi) 2024-05-16
IL210912A0 (en) 2011-04-28
IL210912B (en) 2019-03-31
IL262657A (en) 2018-12-31
BRPI0823046A2 (pt) 2015-07-28
ES2978373T3 (es) 2024-09-11
ES2527943T3 (es) 2015-02-02
KR20110067099A (ko) 2011-06-21
SI3604324T1 (sl) 2024-06-28
JP2011530592A (ja) 2011-12-22
CN102149724A (zh) 2011-08-10
AU2008360625A1 (en) 2010-02-18
MX2011001506A (es) 2011-03-15
EP2321337B9 (en) 2016-11-30
ES2749190T3 (es) 2020-03-19
US20120122759A1 (en) 2012-05-17

Similar Documents

Publication Publication Date Title
IL262657B (en) Methods for removing a contaminant using natural protein transfer in ion exchange membrane chromatography
GB2437519B (en) Method for separation
ZA201002497B (en) Method for making contact lenses
IL211217A0 (en) Methods for evaluating chromatography column performance
GB0619534D0 (en) Recap alignment clamp
EP2313172A4 (en) BLOCK CONFIGURATION FOR DISTILLATION ON LARGE SCALE MEMBRANE
GB2462516B (en) Methods for operating a filtration system
EP2170479A4 (en) RECOVERY PROCESS
IL205107A0 (en) Method for purifying fc-fusion proteins
EP2263105A4 (en) METHOD FOR PERFORMING STRAINED POLARIZATION FILTRATION
EP2241095A4 (en) Techniques for transfer error recovery
EP2519536A4 (en) PROTEIN PURIFICATION BY ION EXCHANGE
FR2911793B1 (fr) Procede de separation par chromatographie
EP1979927A4 (en) REDEPOSITION TECHNIQUE FOR MEMBRANE FIXATION
PL2650302T3 (pl) Sposób usuwania endotoksyny z białek
EP2322498A4 (en) PROCESS FOR REMOVING DIBENO FUELS
PL2257537T3 (pl) Sposób oczyszczania epichlorohydryn
EP2216408A4 (en) METHOD FOR IMPROVING SALINITY TOLERANCE
GB0805298D0 (en) SAL (semi-active-laser) target-detection method
GB0616375D0 (en) An apparatus for facilitating disaster recovery
EP2005930A4 (de) Verfahren zur faltenentfernung
LT2134498T (lt) Autogeninių apdorojimų būdas
EP2129451A4 (en) METHOD FOR REMOVING STYRENE
FI20065014A0 (fi) Menetelmä betaiinin erottamiseksi
AU2008900866A0 (en) Method for Desalinating Water